PHARMACOLOGY EDUCATION RESEARCH FO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Principal Officer

PAUL A INSEL MD

Phone

8588225590

Tax Period

2023-10-01 to 2024-09-30

PHARMACOLOGY EDUCATION RESEARCH FOUNDATION, founded in 1989, is a small nonprofit that reported $148K in total revenue in fiscal year 2023. Revenue fell 29% from the prior year — a significant decline worth monitoring. Expenses of $215K exceeded revenue, resulting in a 45% operating deficit.

Mission

THE FOUNDATION SUPPORTS RESEARCH AND TEACHING ACTIVITIES IN THE AREAS OF MOLECULAR PHARMACOLOGY, CARDIOVASCULAR PHARMACOLOGY, MOLECULAR BIOLOGY, AND NEUROBIOLOGY.

Program Service Accomplishments

Program 1

Expenses: $163,855

SPECIFIC PROJECTS INCLUDE STUDIES OF MECHANISMS INVOLVED IN SIGNAL TRANSDUCTION AND GENETIC REGULATION OF CELL FUNCTION AS WELL AS INVESTIGATION INTO THE MOLECULAR BASIS OF DISORDERS SUCH AS...

SPECIFIC PROJECTS INCLUDE STUDIES OF MECHANISMS INVOLVED IN SIGNAL TRANSDUCTION AND GENETIC REGULATION OF CELL FUNCTION AS WELL AS INVESTIGATION INTO THE MOLECULAR BASIS OF DISORDERS SUCH AS HYPERTENSION AND CANCER.THE FOUNDATION SUPPORTS EDUCATIONAL ACTIVITIES OF DOCTORAL (PH.D.) STUDENTS, POSTDOCTORAL SCHOLARS, AND VISITING SCIENTISTS. THE FOUNDATION HAS ALSO ALLOCATED FUNDS TO SUPPORT STUDENT AND FELLOW TRAVEL TO MEETINGS, CONFERENCES HELD AT UCSD AND ELSEWHERE, STUDENT INVITED SEMINAR SPEAKERS, AND PARTIAL FELLOWSHIP SUPPORT OF GRADUATE STUDENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $135,000

Program Service Revenue $13,262

Investment Income $0

Other Revenue $0

TOTAL REVENUE $148,262

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $163,855

Other Expenses $214,559

TOTAL EXPENSES $214,559

Year-over-Year Comparison

	2023	2022	Change
Revenue	$148,262	$210,265	-0.3%
Expenses	$214,559	$282,265	-0.2%
Net Income	$-66,297	$-72,000	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
PAUL A INSEL MD	PRESIDENT	Officer Director	$0	$0	$0
PALMER TAYLOR PHD	TREASURER	Officer Director	$0	$0	$0
MICHAEL KARIN	BOARD MEMBER	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$148,262	$214,559	$1,007,410	$-66,297
2023	$210,265	$282,265	$1,073,707	$-72,000
2022	$309,507	$237,939	$1,145,707	$71,568
2021	$206,745	$105,254	$1,074,139	$101,491
2020	$205,393	$122,845	$972,648	$82,548
2019	$204,195	$210,822	$890,100	$-6,627

PHARMACOLOGY EDUCATION RESEARCH FOUNDATION